 immunocytochem detect kappa lambda light chain region subgroup human b-cell malign sensit immunoperoxidas method specif anti-light chain antisera light chain variabl region VL natur cytoplasm cell surfac Ig human monoclon plasma cell lymphocyt immunocytochem character cig sig antisera specif kappa light chain kappa subgroup kappa kappa II kappa iii kappa IV lambda light chain lambda subgroup lambda ii/v IV lambda VI cytospin prepar bone marrow- peripher blood- lymph node-deriv cell patient multipl myeloma amyloidosi AL waldenstrom macroglobulinemia low- mid- high-grad b-cell malign kappa subgroup cig sig deparaffin enzym treatment formalin-fix paraffin-embed specimen patient monoclon serum urinari ig complet concord VL subgroup secret Ig cig sig percentag distribut kappa subgroup sig cell patient chronic lymphocyt leukemia cll cytomorpholog type b-cell malign kappa- lambda-typ benc jone protein patient multipl myeloma amyloidosi AL waldenstrom macroglobulinemia contrast plasma cell lymphocytoid plasma cell diseas rel predomin certain VL subgroup ie kappa IV iii lambda IV absenc amyloid-associ lambda VI subgroup cll diseas immunocytochem techniqu possibl rapid b-cell monoclon evid select express certain VL gene human b-cell neoplasia